In the only paper to date investigating AMPK and GVHD, 5 days of metformin administration ameliorated GVHD severity and decreased disease lethality, with fewer Th17 and Th1 and increased Treg cells recovered from metformin-treated recipients (49). Here, PRKAA1 is linked to graft versus host disease.